Retinoid binding proteins and nuclear receptors are expressed in the developing mouse inner ear. Here, we report that the retinaldehyde dehydrogenase 2 (Raldh2) gene, whose product is involved in the enzymatic generation of retinoic acid (RA), exhibits a restricted expression pattern during mouse inner ear ontogenesis. The Raldh2 gene is ®rst expressed at embryonic day (E) 10.5 in a V-shaped medio-dorsal region of the otocyst outer epithelium, which evolves as two separate domains upon otocyst morphogenesis. At E14.5, Raldh2 is expressed in two areas of the utricle epithelium and speci®c regions of the saccule and cochlear mesenchyme. Later, Raldh2 transcripts are restricted to two cochlear areas, the stria vascularis and Reissner membrane. Raldh2 mesenchymal expression did not correlate with migrating neural crestderived melanoblasts. These restricted expression domains may correspond to speci®c sites of RA synthesis during inner ear morphogenesis. q
Several data support a role for retinoic acid (RA) in the developing inner ear. Endogenous RA has been detected in the differentiating mouse cochlea (Kelley et al., 1993) , and inner ear structures are differentially sensitive to exogenous RA (Choo et al., 1998) . Nuclear RA receptors (Romand et al., 1998; Raz and Kelley, 1999) and cellular retinoid binding proteins (Ylikoski et al., 1994; Romand et al., 2000) are expressed in the developing cochlea. Moreover, mouse embryos possess three distinct retinaldehyde dehydrogenases (RALDH1, RALDH2 and RALDH3) that catalyze RA formation (Gru Èn et al., 2000; Li et al., 2000; Mic et al., 2000; and references therein) . The Raldh2 gene is expressed in discrete embryonic areas which correlate with sites of RA production (Niederreither et al., 1997; Berggren et al., 1999; Haselbeck et al., 1999; McCaffery and Dra Èger, 2000) . Disruption of the mouse Raldh2 gene results in severe embryonic abnormalities, including impaired hindbrain segmentation and otocyst gene expression (Niederreither et al., 1999 (Niederreither et al., , 2000 . We show here that Raldh2 expression appears in a de®ned region of the otocyst epithelium at E10.5. Furthermore, spatially restricted expression is found in both vestibular and cochlear components during later development.
Results
No expression of Raldh2 was detected at E8.5 in the otic placode or at E9.5 in the closed otocyst, although transcripts were expressed in other embryonic areas (see Niederreither et al., 1997) . Raldh2 transcripts were detected in a V-shaped domain along the medio-dorsal aspect of the E10.5 otocyst outer wall (Fig. 1A,B) , which evolved as two parallel stripes in slightly older embryos (Fig. 1C) . Raldh2 expression pattern was distinct from that of NKx5.1, which extends more dorsally along the outer wall and is maximal towards its anterior and posterior poles (Fig. 1D) and of Pax2, which marks the ventral inner otocyst wall (Fig. 1E ) (see also Rinkwitz-Brandt et al., 1996; Hidalgo-Sanchez et al., 2000) . Hybridization of serial sections con®rmed the restricted expression of Raldh2 toward a medial portion of www.elsevier.com/locate/modo the outer otocyst epithelium (Fig. 2) . Expression was excluded from the dorsalmost otocyst epithelium, which contains the developing endolymphatic duct ( Fig. 2A) , but appeared on subsequent section planes (Fig. 2B,C) and became highly restricted as sections progressed ventrally (Fig. 2D ). Raldh2 expression was excluded from the anterior and ventralmost portion of the otocyst, characterized by its thicker epithelium (Fig. 2E,F) .
At E11.5, two domains of expression were detected in the lateral portion of the differentiating otocyst, within the cochlear duct and at the base of an outgrowing semi-circular canal, opposite to the endolymphatic duct (Fig. 3A) . None of the cranial nerve ganglia surrounding the otocyst displayed Raldh2 expression (data not shown). However, RALDH2 immunoreactivity has been reported in a subset of neurons of the VII/VIIIth cranial nerve in the chicken embryo (Berggren et al., 1999) .
At E14.5, as the main components of the developing inner ear had formed, Raldh2 transcripts were found in discrete vestibular and cochlear components (Fig. 3B±D ). Vestibular expression was localized to two domains in the utricule epithelium, and along the lateral edge of the saccule mesenchyme (Fig. 3B ). In addition, Raldh2 was expressed at the level of the basal turn of the cochlear mesenchyme, just above the edge of the cochlear canal towards the modiolus (Fig. 3D) . No signal was detected in the sensory epithelium of the cochlea and the nervous structures, such as the spiral ganglion and the auditory nerve (Fig. 3C , data not shown). At E16.5 (Fig. 3E,F) , the presumptive stria vascularis and the Reissner membrane that start to differentiate from the surrounding mesenchyme showed localized Raldh2 signal. Shortly before birth, when most inner ear structures are well differentiated (Sher, 1971) , Raldh2 transcripts were restricted to speci®c areas of the vestibular Fig. 1A ) progresses from dorsal (A) to ventral (F) regions of the otocyst and is also slightly biased from posterior (A) to anterior (F). Ba, branchial arches; Ed, endolymphatic duct; Hb, hindbrain; Ot, otocyst. epithelium (Fig. 3G) and to two regions of the cochlea, the stria vascularis and the Reissner membrane (Fig. 3H,I ).
We compared Raldh2 transcript distribution with that of Trp-2 (tyrosinase related protein-2), which marks the migrating neural crest-derived melanoblasts that eventually populate the stria vascularis (Cable et al., 1995) . No correlation was found between Raldh2 and Trp-2 transcripts at early stages. At E12.5, Trp-2-positive cells were mainly found in the mesenchyme underlying the ventral side of the presumptive cochlear canal ( Fig. 4B ; Cable et al., 1995) . No Raldh2 transcripts were detected in this location (Fig. 4A) . Distinct spatial distributions were seen at E14.5, when melanoblasts began to be localized to the developing stria vascularis (Fig. 4D) and Raldh2 transcripts were con®ned to the medial cochlear mesenchyme (Fig. 4C) . At E16.5 (data not shown) and E18.5 (Fig. 4E±H) , both Raldh2 Fig. 3 . Region-speci®c expression of Raldh2 during inner ear differentiation. The section planes are coronal, except where otherwise indicated. At least two domains of expression are visible at E11.5 (A), one in the cochlear duct (Cd) and another one near a semi-circular canal (Scc). At E14.5 (B±D), two localized Raldh2 expression domains are present in the utricule epithelium (Ut), while labelling is restricted to mesenchymal areas around the saccule (Sa) and the basal cochlear canal (bCc). No expression is observed in nervous structures such as the spiral ganglion (Sg). At E16.5 (E,F), Raldh2 transcripts become more restricted to two cochlear regions that correspond to the presumptive stria vascularis (arrows) and the Reissner membrane (arrowheads). Two days later (E18.5), several regions show speci®c labelling in the vestibular (V) and the cochlear components (C) of the inner ear (G, arrows). At the cochlear level (H,I), transcripts are speci®cally restricted to the stria vascularis (arrows) and the Reissner membrane (arrowheads). aCc, apical cochlear canal; bCc, basal cochlear canal; C, cochlear part of the inner ear; Cd, cochlear duct; D, dorsal; Cd, cochlear duct; Ed, endolymphatic duct; Ko, Ko Èlliker's organ; M, medial; Mo, modiolus; Oc, otic capsule; Rm, Reissner membrane; Sa, saccule; Scc, semi-circular canal; Sg, spiral ganglion; Sv, Stria vascularis; Ut, utricule; V, vestibular part of the inner ear. Scale bars: 200 mm.
and Trp-2 transcripts were present in the stria vascularis, but Raldh2 was additionally detected in the Reissner membrane. Thus, Raldh2 may be induced in the stria vascularis melanoblasts after their migration, and/or be expressed in another cell type of the stria.
In conclusion, the mouse Raldh2 gene is ®rst expressed in a de®ned domain of the otocyst by E10.5 and remains expressed, throughout development, in discrete regions of the inner ear. In contrast, Raldh3 was shown to be expressed in the early otocyst by E9.5±10.5, but not at later stages (Gru Èn et al., 2000; Mic et al., 2000) . These Raldh expression sites could de®ne areas of local RA production (or possibly diffusion gradients) required for morphogenesis of the inner ear.
Materials and methods
The Raldh2, NKx5.1, Pax2 and Trp-2 probes were described in Dressler et al. (1990) , Cable et al. (1992) , Rinkwitz-Brandt et al. (1996) , and Niederreither et al. (1997) , respectively. The in situ hybridization protocols are given in De Âcimo et al. (1995) . Embryos up to E10.5 were sectioned in paraf®n wax, and later developmental stages were analyzed on cryosections. 
